Rheumission Marks Autoimmune Awareness Month By Passing Key Milestones

LOS ANGELES (March 2025) - Rheumission, the first virtual rheumatology clinic offering specialized, integrative, whole-person care covered by insurance, announced today that as we enter March as Autoimmune Awareness Month, the just over one-year-old company has made significant strides in its mission to change the lives of millions of people with autoimmune disease.

To date, Rheumission, which officially launched in January 2024, has: 

  • Treated 400+ patients across 1,500+ appointments 
  • Provided 88% of undiagnosed patients a diagnosis in under 50 days 
  • Helped 70% of patients achieve a significant decrease in disease activity (as measured by the RAPID3 assessment) after 90 days
  • Helped 15% of patients go into remission without use of biologics 
  • Lowered the biologics prescription rate among patients to 6% compared to the average biologics prescription rate of 32% among traditional rheumatology patients 

Rheumission’s protocol is grounded in evidence-based, whole-person care protocols that are validated by the American College of Rheumatology and the American College of Lifestyle Medicine. Rheumission’s program is the first rheumatology protocol to focus on biologics reduction by combining the two disciplines in combination with anti-inflammatory diet and mental health interventions to treat patients with a multidisciplinary approach within the same practice. 

Patients meet with their care team of an integrative rheumatologist, lifestyle medicine provider, registered dietitian, autoimmune pain psychologist and care coordinator via telehealth appointments in coordination with ongoing interactions with the care team via in-app messages and features.

“It’s been my life’s mission – as an autoimmune patient, advocate, investor and entrepreneur – to reinvent and improve the way we treat autoimmune conditions, both for the millions of people around the world suffering, and for my own 10 grandchildren who have genetic markers for these diseases,” explains Dr. Bonnie Feldman, Co-founder and Chief Patient Officer. “In just over a year helping people, our progress so far and momentum going into the rest of 2025 is incredibly exciting.” 

There are more than 100 known autoimmune diseases and these affect approximately 50 million people in the US alone, about 16% of the population – more than cancer or heart disease. Also, autoimmune disease disproportionately affects women, with 8 out of ten women living with some form of autoimmune disease today. 

About Rheumission

Rheumission is the first virtual rheumatology clinic offering specialized, integrative, whole-person care covered by insurance. Launched in January 2024, our mission is remission: to change the lives of people with autoimmune disease, which affects 50 million people in the US, 80% of which are women. For more information, visit www.rheumission.com.